沙利多胺通过抑制MAPKs和NF-κB信号通路来缓解类似亚托皮炎的反应
Miaomiao Wang1,2, Yujie Xiong3
1Department of Traditional Chinese Medicine, First Affiliated Hospital of Bengbu Medical University, Bengbu, 233000, China. wmmiao876@hotmail.com.
Archives of dermatological research
|April 1, 2025
概括
沙利德胺有效地通过减少炎症和抑制关键信号通路来治疗阿托皮炎 (AD). 这种天然化合物对开发新的抗老年痴呆症疗法充满希望.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 亚托皮炎 (AD) 是一种慢性炎症性皮肤疾病.
- 来自Acer tegmentosum的沙利德化物,正在研究其治疗潜力.
- 了解其在阿尔茨海默病中的机制对于治疗开发至关重要.
研究的目的:
- 调查沙利德对亚托皮性皮肤炎 (AD) 的治疗效果.
- 阐明沙利德胺在阿尔茨海默病中的作用的基本机制.
- 在AD的体外和体外模型中评估salidroside的疗效.
主要方法:
- 在小鼠中使用2,4-丁基 (DNCB) 诱导了类似AD的皮肤病变.
- 沙利德胺被口服给小鼠;组织学,伤和脏体重变化被评估.
- 在体外研究中使用了TNF-α/IFN-γ刺激的HaCaT细胞和初级角质细胞.
- 使用RT-qPCR和西式斑点分析了亲炎性标记物和通路蛋白.
主要成果:
- 在刺激细胞中,沙利德化物显著降低了促炎性细胞因子和化学因子.
- 在小鼠中,口服salidroside缓解了DNCB诱导的AD类症状和皮肤炎症.
- 在体外和体内,沙利化物治疗使MAPK和NF-κB信号通路失活.
- 组织学分析证实了炎症细胞透的减弱.
结论:
- 沙利德胺在治疗亚托皮性皮肤炎方面显示出显著的治疗潜力.
- 沙利德胺的抗炎作用是通过对MAPK和NF-κB通路的失活进行调解的.
- 沙利德化物代表了一种有前途的天然化合物,用于开发新的抗老年痴呆症药物.
相关概念视频
02:26NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
110
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
110
01:20The JAK-STAT Signaling Pathway
8.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.5K
02:02Responses to Salt Stress
12.9K
Salt stress—which can be triggered by high salt concentrations in a plant’s environment—can significantly affect plant growth and crop production by influencing photosynthesis and the absorption of water and nutrients.
12.9K
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
91
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
91
01:16TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K